109 related articles for article (PubMed ID: 3720831)
1. Comparison of the actions of serotoninergic agents on human saphenous veins and platelets.
Victorzon M; Tapparelli C; Müller-Schweinitzer E
Eur J Pharmacol; 1986 May; 124(1-2):107-11. PubMed ID: 3720831
[TBL] [Abstract][Full Text] [Related]
2. Heterogeneity of 5-HT receptor subtypes in isolated human femoral and saphenous veins.
Glusa E; Müller-Schweinitzer E
Naunyn Schmiedebergs Arch Pharmacol; 1993 Feb; 347(2):133-6. PubMed ID: 8474533
[TBL] [Abstract][Full Text] [Related]
3. Vascular 5-HT1-like receptors that mediate contraction of the dog isolated saphenous vein and carotid arterial vasoconstriction in anaesthetized dogs are not of the 5-HT1A or 5-HT1D subtype.
Perren MJ; Feniuk W; Humphrey PP
Br J Pharmacol; 1991 Jan; 102(1):191-7. PubMed ID: 1675143
[TBL] [Abstract][Full Text] [Related]
4. A comparison of 5-hydroxytryptamine receptors mediating contraction in rabbit aorta and dog saphenous vein: evidence for different receptor types obtained by use of selective agonists and antagonists.
Feniuk W; Humphrey PP; Perren MJ; Watts AD
Br J Pharmacol; 1985 Nov; 86(3):697-704. PubMed ID: 2933110
[TBL] [Abstract][Full Text] [Related]
5. GR43175, a selective agonist for the 5-HT1-like receptor in dog isolated saphenous vein.
Humphrey PP; Feniuk W; Perren MJ; Connor HE; Oxford AW; Coates LH; Butina D
Br J Pharmacol; 1988 Aug; 94(4):1123-32. PubMed ID: 2850055
[TBL] [Abstract][Full Text] [Related]
6. The actions of 5-hydroxytryptamine receptor agonists and antagonists at pre- and postjunctional level on the canine saphenous vein.
Paiva MQ; Caramona MM; Osswald W
Naunyn Schmiedebergs Arch Pharmacol; 1988 Dec; 338(6):616-22. PubMed ID: 2977424
[TBL] [Abstract][Full Text] [Related]
7. 5-HT1-like receptors mediate 5-hydroxytryptamine-induced contraction of human isolated basilar artery.
Parsons AA; Whalley ET; Feniuk W; Connor HE; Humphrey PP
Br J Pharmacol; 1989 Feb; 96(2):434-40. PubMed ID: 2538194
[TBL] [Abstract][Full Text] [Related]
8. Contractile effects of 8-hydroxy-2-(di-n-propylamino)tetralin and flesinoxan in human isolated basilar artery.
Parsons AA; Motevalian M; Whalley ET
Eur J Pharmacol; 1991 Sep; 202(1):17-23. PubMed ID: 1664803
[TBL] [Abstract][Full Text] [Related]
9. Analysis of the 5-HT receptor in rabbit saphenous vein exemplifies the problems of using exclusion criteria for receptor classification.
Martin GR; MacLennan SJ
Naunyn Schmiedebergs Arch Pharmacol; 1990 Aug; 342(2):111-9. PubMed ID: 2234095
[TBL] [Abstract][Full Text] [Related]
10. Characterization of 5-hydroxytryptamine receptors mediating contractions in basilar arteries from stroke-prone spontaneously hypertensive rats.
Nishimura Y
Br J Pharmacol; 1996 Mar; 117(6):1325-1333. PubMed ID: 8882632
[TBL] [Abstract][Full Text] [Related]
11. Studies on the mechanism of 5-HT1 receptor-induced smooth muscle contraction in dog saphenous vein.
Sumner MJ; Feniuk W; McCormick JD; Humphrey PP
Br J Pharmacol; 1992 Mar; 105(3):603-8. PubMed ID: 1320980
[TBL] [Abstract][Full Text] [Related]
12. Modulation by 5-HT1A receptors of the 5-HT2 receptor-mediated tachykinin-induced contraction of the rat trachea in vitro.
Germonpré PR; Joos GF; Pauwels RA
Br J Pharmacol; 1998 Apr; 123(8):1571-8. PubMed ID: 9605563
[TBL] [Abstract][Full Text] [Related]
13. A nonclassical 5-hydroxytryptamine receptor positively coupled with adenylate cyclase in the central nervous system.
Dumuis A; Bouhelal R; Sebben M; Cory R; Bockaert J
Mol Pharmacol; 1988 Dec; 34(6):880-7. PubMed ID: 2849052
[TBL] [Abstract][Full Text] [Related]
14. Differential classification of vascular smooth muscle and endothelial cell 5-HT receptors by use of tryptamine analogues.
Leff P; Martin GR; Morse JM
Br J Pharmacol; 1987 Jun; 91(2):321-31. PubMed ID: 3607360
[TBL] [Abstract][Full Text] [Related]
15. Contractile 5-HT1 receptors in human isolated pial arterioles: correlation with 5-HT1D binding sites.
Hamel E; Bouchard D
Br J Pharmacol; 1991 Jan; 102(1):227-33. PubMed ID: 2043924
[TBL] [Abstract][Full Text] [Related]
16. 5-HT1-like receptors mediate contractions of the rabbit saphenous vein.
van Heuven-Nolsen D; Tysse Klasen TH; Luo QF; Saxena PR
Eur J Pharmacol; 1990 Dec; 191(3):375-82. PubMed ID: 2086249
[TBL] [Abstract][Full Text] [Related]
17. Contractions to 5-hydroxytryptamine in human coronary artery and human saphenous vein.
Borton M; Neligan M; Wood F; Dervan P; Goggins K; Docherty JR
Br J Clin Pharmacol; 1990; 30 Suppl 1(Suppl 1):107S-108S. PubMed ID: 2268504
[TBL] [Abstract][Full Text] [Related]
18. Influence of the endothelium and nitric oxide on the contractile responses evoked by 5-HT1D receptor agonists in the rabbit isolated saphenous vein.
Valentin JP; Bonnafous R; John GW
Br J Pharmacol; 1996 Sep; 119(1):35-42. PubMed ID: 8872354
[TBL] [Abstract][Full Text] [Related]
19. Pharmacological properties of the receptor(s) involved in the 5-hydroxytryptamine-induced contraction of the feline middle cerebral artery.
Hamel E; Robert JP; Young AR; MacKenzie ET
J Pharmacol Exp Ther; 1989 Jun; 249(3):879-89. PubMed ID: 2732950
[TBL] [Abstract][Full Text] [Related]
20. Recombinant saphenous vein 5-HT1B receptors of the rabbit: comparative pharmacology with human 5-HT1B receptors.
Wurch T; Palmier C; Colpaert FC; Pauwels PJ
Br J Pharmacol; 1997 Jan; 120(1):153-9. PubMed ID: 9117091
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
